BB Biotech: Our new core position in the biotech sector. AI will generate new therapies and accelerate R&D processes.

Since the end of 2022, the investment trend "AI" has focused on chip stocks, memory providers, and network equipment manufacturers. This represents the largest infrastructure expansion in history, as NVIDIA CEO Huang commented. Accordingly, business has accelerated. However, there will come a time when players will look beyond the immediate horizon. AI is accelerating the transition to robotics, including humanoids. AI will also help in discovering new drug candidates and treating cancer with personalized therapies. At the same time, the speed of...